|
1
|
Mankin HJ: Nontraumatic necrosis of bone
(osteonecrosis). N Engl J Med. 326:1473–1479. 1992.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maillefert JF, Tavernier C, Toubeau M and
Brunotte F: Non-traumatic avascular necrosis of the femoral head. J
Bone Joint Surg Am. 78:473–474. 1995.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yamaguchi R, Yamamoto T, Motomura G,
Ikemura S and Iwamoto Y: Incidence of nontraumatic osteonecrosis of
the femoral head in the Japanese population. Arthritis Rheum.
63:3169–3173. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang W, Sun QM, Zhang FQ, Zhang QL, Wang
LG and Wang WJ: Core decompression combined with autologous bone
marrow stem cells versus core decompression alone for patients with
osteonecrosis of the femoral head: A meta-analysis. Int J Surg.
69:23–31. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Andriolo L, Merli G, Tobar C, Altamura SA,
Kon E and Filardo G: Regenerative therapies increase survivorship
of avascular necrosis of the femoral head: A systematic review and
meta-analysis. Int Orthop. 42:1689–1704. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mutijima E, Maertelaer VD, Deprez M,
Malaise M and Hauzeur JP: The apoptosis of osteoblasts and
osteocytes in femoral head osteonecrosis: Its specificity and its
distribution. Clin Rheumatol. 33:1791–1795. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Boregowda SV, Krishnappa V, Strivelli J,
Haga CL, Booker CN and Phinney DG: Basal p53 expression is
indispensable for mesenchymal stem cell integrity. Cell Death
Differ. 25:679–692. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim T, Kim K, Lee SH, So HS, Lee J, Kim N
and Choi Y: Identification of LRRc17 as a negative regulator of
receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast
differentiation. J Biol Chem. 284:15308–15316. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang A, Ren M, Song Y, Wang X, Wang Q,
Yang Q, Liu H, Du Z, Zhang G and Wang J: MicroRNA expression
profiling of bone marrow mesenchymal stem cells in steroid-induced
osteonecrosis of the femoral head associated with osteogenesis. Med
Sci Monit. 24:1813–1825. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hong N, Kim BJ, Kim CH, Baek KH, Min YK,
Kim DY, Lee SH, Koh JM, Kang MI and Rhee Y: Low plasma level of
leucine-rich repeat-containing 17 (LRRc17) is an independent and
additive risk factor for osteoporotic fractures in postmenopausal
women. J Bone Miner Res. 31:2106–2114. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kim BJ, Lee SH and Koh JM: Potential
biomarkers to improve the prediction of osteoporotic fractures.
Endocrinol Metab (Seoul). 35:55–63. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ficat RP: Idiopathic bone necrosis of the
femoral head. Early diagnosis and treatment. J Bone Joint Surg Br.
67:3–9. 1985.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tan SL, Ahmad TS, Selvaratnam L and
Kamarul T: Isolation, characterization and the multi-lineage
differentiation potential of rabbit bone marrow-derived mesenchymal
stem cells. J Anat. 222:437–450. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ko JY, Wang FS, Wang CJ, Wong T, Chou WY
and Tseng SL: Increased dickkopf-1 expression accelerates bone cell
apoptosis in femoral head osteonecrosis. Bone. 46:584–591.
2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Phetfong J, Sanvoranart T, Nartprayut K,
Nimsanor N, Seenprachawong K, Prachayasittikul V and Supokawej A:
Osteoporosis: The current status of mesenchymal stem cell-based
therapy. Cell Mol Biol Lett. 21(12)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Albers J, Keller J, Baranowsky A, Beil FT,
Catala-Lehnen P, Schulze J, Amling M and Schinke T: Canonical Wnt
signaling inhibits osteoclastogenesis independent of
osteoprotegerin. J Cell Biol. 200:537–549. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tornero-Esteban P, Peralta-Sastre A,
Herranz E, Rodriguez-Rodriguez L, Mucientes A, Abasolo L, Marco F,
Fernandez-Gutierrez B and Lamas JR: Altered expression of wnt
signaling pathway components in osteogenesis of mesenchymal stem
cells in osteoarthritis patients. PLoS One.
10(e0137170)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen J, Tu X, Esen E, Joeng KS, Lin C,
Arbeit JM, Rüegg MA, Hall MN, Ma L and Long F: WNT7B promotes bone
formation in part through mTORC1. PLoS Genet.
10(e1004145)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rodda SJ and McMahon AP: Distinct roles
for Hedgehog and canonical Wnt signaling in specification,
differentiation and maintenance of osteoblast progenitors.
Development. 133:3231–3244. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Krause U, Harris S, Green A, Ylostalo J,
Zeitouni S, Lee N and Gregory CA: Pharmaceutical modulation of
canonical Wnt signaling in multipotent stromal cells for improved
osteoinductive therapy. Proc Natl Acad Sci USA. 107:4147–4152.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nagayama M, Iwamoto M, Hargett A, Kamiya
N, Tamamura Y, Young B, Morrison T, Takeuchi H, Pacifici M,
Enomoto-Iwamoto M and Koyama E: Wnt/beta-catenin signaling
regulates cranial base development and growth. J Dent Res.
87:244–249. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tamamura Y, Otani T, Kanatani N, Koyama E,
Kitagaki J, Komori T, Yamada Y, Costantini F, Wakisaka S, Pacifici
M, et al: Developmental regulation of Wnt/beta-catenin signals is
required for growth plate assembly, cartilage integrity, and
endochondral ossification. J Biol Chem. 280:19185–19195.
2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cho HH, Kim YJ, Kim SJ, Kim JH, Bae YC, Ba
B and Jung JS: Endogenous Wnt signaling promotes proliferation and
suppresses osteogenic differentiation in human adipose derived
stromal cells. Tissue Eng. 12:111–121. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ring L, Neth P, Weber C, Steffens S and
Faussner A: β-catenin-dependent pathway activation by both
promiscuous ‘canonical’ WNT3a-, and specific ‘noncanonical’ WNT4-
and WNT5a-FZD receptor combinations with strong differences in LRP5
and LRP6 dependency. Cell Signal. 26:260–267. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang S, Chen X, Hu Y, Wu J, Cao Q, Chen S
and Gao Y: All-trans retinoic acid modulates Wnt3A-induced
osteogenic differentiation of mesenchymal stem cells via activating
the PI3K/AKT/GSK3β signalling pathway. Mol Cell Endocrinol.
422:243–253. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yamane T, Kunisada T, Tsukamoto H,
Yamazaki H, Niwa H, Takada S and Hayashi SI: Wnt signaling
regulates hemopoiesis through stromal cells. J Immunol.
167:765–772. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Takahashi N, Maeda K, Ishihara A, Uehara S
and Kobayashi Y: Regulatory mechanism of osteoclastogenesis by
RANKL and Wnt signals. Front Biosci (Landmark Ed). 16:21–30.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Oishi I, Suzuki H, Onishi N, Takada R,
Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, et
al: The receptor tyrosine kinase Ror2 is involved in non-canonical
Wnt5a/JNK signalling pathway. Genes Cells. 8:645–654.
2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sato A, Yamamoto H, Sakane H, Koyama H and
Kikuchi A: Wnt5a regulates distinct signalling pathways by binding
to Frizzled2. EMBO J. 29:41–54. 2010.PubMed/NCBI View Article : Google Scholar
|
